KAWASAKI DISEASE: AN IMPORTANT CAUSE OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN PEDIATRICS
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Kawasaki disease (KD) is an acute febrile, systemic vasculitic sindrome affecting medium-sized arteries, unknown aetiology, probably multifactorial, which affects mainly infants and early childhood. KD is characterized by fever, conjunctivitis nonexudative bilateral conjunctivitis, erythema lips and oral mucosa, changes in the extremities, erythematous rash and cervical lymphadenopathy. combines risk of developing ecstasies or aneurisms of the coronary arteries that may lead to ischemic heart disease, myocardial infarction or sudden death. Treatment with intravenous immunoglobulin is generally effective but its mechanism of action is still unclear.
The development of a diagnostic test, a more specific treatment and ultimately the prevention of this potentially fatal disease in children from all depend on continued progress in understanding the etiopathogenesis of this fascinating disease.
The purpose of this review is to outline the main hypothesis on the genesis of KD, diagnostic criteria, treatment options currently available and the importance of follow-up.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.